Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 45865-184

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 45865-184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

184 (45865 184)

This is a description of Tramadol HCL ER Tablets 300mg, a generic version of Ultram ER. It is a medication used to treat pain and may cause dizziness or drowsiness. It is recommended to avoid alcohol while taking this medication. The tablets should be taken every few hours as needed for pain relief. It is important to follow the dosage instructions and not to share the medication with others as it is prohibited by federal law.*

FDA Label Image

Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)

FDA Label Image

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)

This text provides data on Tramadol concentration (ng/mL) at different time points and dosages of Tramadol Hydrochloride Extended-Release Tablets and Tramadol Hydrochloride Tablets. The table includes concentrations ranging from 350 ng/mL to 50 ng/mL over time intervals.*

FDA Label Image

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)

This text provides concentration levels of M1 over time for Tramadol Hydrochloride Extended-Release Tablets and Tramadol Hydrochloride Tablets. It shows the concentrations in ng/mL at different time points.*

FDA Label Image

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)

This data illustrates the percentage of patients achieving various levels of pain relief with Tramadol Hydrochloride Extended-Release Tablets at different dosages compared to a placebo. The study focuses on the WOMAC Pain Responder Analysis and the response threshold, showing the effectiveness of different dosages in providing pain relief to patients.*

FDA Label Image

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)

This text presents data from a study (Study 015) on Tramadol Hydrochloride Extended-Release Tablets for arthritis pain management. It includes a responder analysis showing the percentage of patients achieving various levels of response thresholds based on percent improvement from baseline. The information in the text can be used to evaluate the effectiveness of the medication in relieving arthritis pain.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.